Table 5 Drug content and percent transmittance
From: Development of nanoemulsion of antiviral drug for brain targeting in the treatment of neuro-AIDS
Sr. no. | Batch | % Transmittance | Drug content |
|---|---|---|---|
1 | B1 | 88.93 ± 0.4% | 92.77 ± 0.3% |
2 | B2 | 87.82 ± 0.8% | 94.19 ± 0.6% |
3 | B3 | 87.79 ± 0.6% | 93.25 ± 0.6% |
4 | B4 | 87.51 ± 0.5% | 93.79 ± 0.8% |